22-23767600-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_213720.3(CHCHD10):​c.42-7C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00324 in 1,162,580 control chromosomes in the GnomAD database, including 120 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 49 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 71 hom. )

Consequence

CHCHD10
NM_213720.3 splice_region, intron

Scores

2
Splicing: ADA: 0.0002668
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.957

Publications

0 publications found
Variant links:
Genes affected
CHCHD10 (HGNC:15559): (coiled-coil-helix-coiled-coil-helix domain containing 10) This gene encodes a mitochondrial protein that is enriched at cristae junctions in the intermembrane space. It may play a role in cristae morphology maintenance or oxidative phosphorylation. Mutations in this gene cause frontotemporal dementia and/or amyotrophic lateral sclerosis-2. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 7 and 19. [provided by RefSeq, Aug 2014]
CHCHD10 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant mitochondrial myopathy with exercise intolerance
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • lower motor neuron syndrome with late-adult onset
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • frontotemporal dementia with motor neuron disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 22-23767600-G-C is Benign according to our data. Variant chr22-23767600-G-C is described in ClinVar as [Benign]. Clinvar id is 473429.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.051 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHCHD10NM_213720.3 linkc.42-7C>G splice_region_variant, intron_variant Intron 1 of 3 ENST00000484558.3 NP_998885.1 Q8WYQ3
CHCHD10NM_001301339.2 linkc.42-7C>G splice_region_variant, intron_variant Intron 1 of 3 NP_001288268.1 Q8WYQ3B5MBW9
CHCHD10NR_125755.2 linkn.140-60C>G intron_variant Intron 1 of 3
CHCHD10NR_125756.2 linkn.139+234C>G intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHCHD10ENST00000484558.3 linkc.42-7C>G splice_region_variant, intron_variant Intron 1 of 3 1 NM_213720.3 ENSP00000418428.3 Q8WYQ3
CHCHD10ENST00000401675.7 linkc.42-7C>G splice_region_variant, intron_variant Intron 1 of 3 5 ENSP00000384973.3 B5MBW9
CHCHD10ENST00000520222.1 linkc.41+234C>G intron_variant Intron 1 of 2 3 ENSP00000430042.1 E5RH03
CHCHD10ENST00000517886.1 linkn.42-60C>G intron_variant Intron 1 of 3 3 ENSP00000429976.1 E5RGN4

Frequencies

GnomAD3 genomes
AF:
0.0143
AC:
2176
AN:
152106
Hom.:
49
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0487
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00589
Gnomad ASJ
AF:
0.00835
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.00764
GnomAD2 exomes
AF:
0.000304
AC:
1
AN:
3292
AF XY:
0.000538
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00194
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00157
AC:
1589
AN:
1010364
Hom.:
71
Cov.:
14
AF XY:
0.00154
AC XY:
762
AN XY:
495120
show subpopulations
African (AFR)
AF:
0.0537
AC:
1053
AN:
19604
American (AMR)
AF:
0.00381
AC:
36
AN:
9442
Ashkenazi Jewish (ASJ)
AF:
0.00933
AC:
141
AN:
15108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26674
South Asian (SAS)
AF:
0.000151
AC:
7
AN:
46378
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29820
Middle Eastern (MID)
AF:
0.00472
AC:
14
AN:
2966
European-Non Finnish (NFE)
AF:
0.000179
AC:
146
AN:
817506
Other (OTH)
AF:
0.00448
AC:
192
AN:
42866
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.583
Heterozygous variant carriers
0
70
140
209
279
349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0143
AC:
2179
AN:
152216
Hom.:
49
Cov.:
32
AF XY:
0.0140
AC XY:
1044
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0487
AC:
2022
AN:
41526
American (AMR)
AF:
0.00588
AC:
90
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00835
AC:
29
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000250
AC:
17
AN:
67990
Other (OTH)
AF:
0.00756
AC:
16
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
112
224
337
449
561
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0119
Hom.:
4
Bravo
AF:
0.0167
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 03, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Lower motor neuron syndrome with late-adult onset;C4014648:Frontotemporal dementia and/or amyotrophic lateral sclerosis 2;C4015513:Autosomal dominant mitochondrial myopathy with exercise intolerance Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.75
DANN
Benign
0.62
PhyloP100
-0.96
PromoterAI
0.014
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00027
dbscSNV1_RF
Benign
0.022
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs567239313; hg19: chr22-24109787; API